Advertisement
UK markets open in 2 hours 22 minutes
  • NIKKEI 225

    37,679.83
    -780.25 (-2.03%)
     
  • HANG SENG

    17,295.93
    +94.66 (+0.55%)
     
  • CRUDE OIL

    82.90
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,324.40
    -14.00 (-0.60%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,570.02
    -1,937.74 (-3.62%)
     
  • CMC Crypto 200

    1,385.69
    -38.41 (-2.70%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Company News For Jul 18, 2018

Eagle Pharmaceuticals (EGRX) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
  • UnitedHealth Group Incorporated’s UNH shares declined 2.6% after the company reported  fiscal second-quarter 2018 total operating cost of $51.9 billion, up 12% year over year

  • Shares of Comerica Incorporated CMA rose 1.3% after the company reported second-quarter fiscal 2018 adjusted earnings of $1.87 per share, surpassing the Zacks Consensus Estimate of $1.62 per share

  • Walmart, Inc.’s WMT shares jumped 0.6% after the company announced that it has entered into a five-year deal with Microsoft Corporation MSFT for expanded use of its cloud and AI technology

  • Shares of The Goldman Sachs Group, Inc. GS declined 0.2% after the company reported fiscal second-quarter 2018 non-compensation expenses of $2.66 billion, up 24% from the year-ago figure


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Comerica Incorporated (CMA) : Free Stock Analysis Report
 
Microsoft Corporation (MSFT) : Free Stock Analysis Report
 
The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Walmart Inc. (WMT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research